INTRODUCTION
Iron defi ciency anemia is a worldwide health problem that affected not only less-developed countries but also remains a problem in developed countries. The lack of iron is the most common cause of anemia defi ned by inadequate amount of red blood cells or low hemoglobin or hematocrit in human population. However anemia is most prevalent complication in cancer patients and can develop in nearly half of patients with solid tumors and hematologic malignancies. Other negative consequences of iron defi ciency on behavior, psychomotor development and growth rate are well established and underline the need to control iron levels 1-7 . Iron plays a vital role in oxygen metabolism, oxygen uptake and electron transport in mitochondria, energy metabolism, cell growth and differentiation, protein and neurotransmitter synthesis or enzyme functions. The daily iron need (for production of red blood cells and cellular metabolism) is about 25 mg per day. The vast majority of these is derived from recycling ageing erythrocytes in macrophages or iron--containing enzymes. Only 1 to 2 mg of iron is absorbed from diet.
Dietary iron is available in two forms: ferrous iron Fe² + and ferric iron Fe³ + . Heme iron which is present in animal food sources, such as meat, poultry and fi sh is generally better absorbed than non-heme iron derived by vegetarian diet. For that reason the risk of iron defi ciency is higher in populations preferring vegetarian eating styles. However there are several conditions that infl uence the loss of iron absorption. They include: chronic or signifi cant weight loss and low intake of foods rich in ascorbic acid 8 . Because dietary intake is limited, iron supplements should be used to prevent and treat iron defi ciency anemia. Lyophilized animal blood is a rich source of iron and proteins of high nutritional and functional quality.
Many kinds of iron supplements are produced from cull animal blood such as pigs, cows and etc. AproFER 1000 is a source of natural and high bioavailable iron produced after the digestion and separation of the enriched fraction of heme iron. AproFER 1000 is a heme iron concentrate. Heme iron is an excellent source of available iron to maintain increase hemoglobin levels.
Proper hemoglobin levels may reduce the risk of anemia. AproFER 1000 is a fi ne dark-colored powder with characteristic odor and taste. Iron in this product is mainly in bivalent form which is the best one to be assimilated by the human organism 9-11 . The bivalent iron is quickly oxidized to its trivalent iron, which when available in its free form can induce the formation of free oxygen radicals which may result in tissue damage 12 .
The body of an average man weighing 70 kg contains 4 g of iron complexes in a variety of proteins. As the complexes involving ions of the iron group have extended wave functions, they are very sensitive to any disturbance. A classic example is the copper complex in polyamine copper dinitrate, where minimal changes in the content of water molecules has a large impact on the electronic structure of the complex 13 . The above described processes have been studied intensively for years due to the abundant presence of free radicals and iron group ions complexes in blood 14 . A very effective method for study of dynamic phenomena is electron paramagnetic resonance (EPR), allowing to determine the concentration of magnetic centers and investigation of relaxation processes. It is particularly useful in the study of magnetic components in blood and in processes involving electron transfer 15-27 .
The aim of this work was to analyze a variety of parameters of AproFER 1000 and AproTHEM, like chemical, dynamic, static magnetic and microbial properties, iron diet supplements.
MATERIAL AND METHODS

Material
AproFER 1000 and AproTHEM are a heme iron concentrates. Heme iron is an excellent source of available iron to maintain / increase hemoglobin levels and can be used for oral administration of iron supplements as a natural source of iron.
AproFER 1000 is a source of natural high bioavailable iron produced after digestion and separation of the enriched fraction of heme iron. AproFER 1000 is a fi ne dark-colored powder with characteristic odor.
Polish Journal of Chemical Technology, 21, 3, 60-67, 10.2478/pjct-2019-0031 The studied AproFER 1000 material was produced by Proliant company (Spain).
The main component of AproTHEM are the red blood cells obtained from animal blood. AproTHEM is a fi ne dark brown powder with characteristic odor and taste. The studied AproTHEM material was produced by Inter JJP company (Poland).
The above mentioned materials were used as iron supplements for clinical tests together with the placebo material being a beetroot powder. It was produced by Bomar company (Poland).
FTIR and Total Iron Content Analysis
The studied materials were subjected to FTIR analysis using Nexus FTIR spectrometer (Thermo Nicolet Corp., USA) with Golden Gate (ATR) attachment.
The analysis of total iron content in the studied iron supplement samples was made using ICP-OES method with Perkin Elmer Optima 5300DV analyzer. The samples of studied materials were mineralized before being subjected to ICP analysis.
Microbial Properties
The microbial stability of iron supplements (AproFER 1000, AproTHEM) and placebo was tested by own method based on method developed by The International Pharmacopoeia.
To establish a standard temperature of storage safety the iron supplements and placebo tablets blister were storage at 4 o C, 25 o C and 37 o C. The microbial test (separately for all used storage temperatures) were carried out under aseptic conditions in tree replications once a month for one year.
The following liquid media were used: Soyabean Casein Digest Agar SCDA (pancreatic digest of casein 17.0 g, papaic digest of soyabean meal 3.0 g, sodium chloride 5.0 g, K 2 HPO 4 2.5 g, glucose 2.3 g in 1 liter of distilled water, pH 7.3 ± 0.2); Thioglycolate Broth TB (L--Cystine: 0.5 g, sodium chloride 2.5 g, yeast extract 5.0 g, glucose 5.0 g, peptone K 15.0 g, sodium thioglycolate 0.5 g, resazurin 0.001 g, agar 0.75 g in 1 liter of distilled water, pH 7.1 ± 0.2).
The solid media were obtained by supplementation with 15 g Agar-Agar (BTL, Poland). The media were prepared according manufacture's (BTL, Poland) instruc-tions and distributed to 10 ml test tubes. The vents of test tubes were closed by cotton wool and then sterilized in autoclave high-pressure saturated steam at 121 o C for 20 minutes. The media were incubated for 14 days. If growth of microorganisms was not detected after that time the media were considered to be sterile.
A single tablet of selected AproFER 1000, Apro THEM and Placebo blister were placed in aseptic conditions to six tubes (for each tested variant) and once again were plugged by cotton wool. The test tubes were placed at incubator at 25 o C (three test tubes with AproFER 1000, AproTHEM and Placebo tablets) and 37 o C (three test tubes with AproFER 1000, AproTHEM and Placebo tablets) for 24 h. Withdraw 0.3 ml from each test tube and placed on appropriate solid media Soyabean Casein Digest Agar or Thioglycolate Agar. The Petri dishes were incubated at 37 o C or 25 o C respectively. The bacteria colony were counted.
Additionally, pathogenic bacteria test were conducted by commercial POLCARGO INTERNATIONAL SP Laboratory (Szczecin, Poland). The following parameters were determined: the presence of Salmonella spp., the presence of Escherichia coli, the presence of coagulase--positive staphylococci, the number of yeast and molds and the total bacteria count TBC at 30 o C.
Magnetic Properties
DC magnetization measurements were carried out using MPMS-7 SQUID magnetometer in 2-300 K temperature range and magnetic fi elds up to 70 kOe in the zero-fi eld--cooling (ZFC) and fi eld cooling (FC) modes. The EPR spectra were recorded using a standard X-band Bruker E 500 spectrometer(ν = 9.45 GHz) with magnetic fi eld modulation of 100 kHz. The microwave power was P = 0.63 mW. The measurements were performed in 4 -290 K temperature range using an Oxford helium-fl ow cryostat.
RESULTS AND DISCUSSION
The obtained FTIR spectra are presented on Figure 1 . As can be seen, spectra of Aprofer 1000 and AproTHEM samples are practically the same. The only difference is the intensity of peaks that can result from the hydration of the materials. AproFER 1000 is characterized by deeper degree of dehydration during the production process. The broad peak at about 3600-3000 cm -1 arises from O-H stretching band of hydroxyls and bound water. It can be observed on both bloods and beetroot samples. The region at about 3000-2900 cm -1 mainly belongs to asymmetric CH 3 and CH 2 stretching of lipids. The 1700-1500 cm -1 region originate from amide bands. 1200-900 cm -1 is a "fi ngerprint" absorption region of carbohydrates and is strongly seen on beetroot spectra. Acids (maltic, citric, etc) show characteristic bands between 1500-1200 cm -1 28-31 .
The ICP analysis was made using the calibration method with the emission line characteristic for the iron at 238 nm. The amount of total iron in the analyzed samples was 0.02, 0.4 and 1.2% by weight for Placebo, AproTHEM and AproFER 1000, respectively.
There were no bacteria growth on Thioglycollate Agar (TA) plates, independently from culture temperature (25 o C or 37 o C) or supplements storage temperature (4 o C or 25 o C or 37 o C). TA is a selective and differential culture medium for bacteria designed to selectively isolate human pathogenic bacteria such as: Staphylococcus aureus ATCC6538, Clostridium perfringens ATCC13124, Salmonella enteritidis ATCC13076. Our results were in agreement with results obtained by commercial PO-LCARGO INTERNATIONAL SP Laboratory. After one year of storage there were no pathogenic bacteria in tested iron supplements and placebo. The detailed results are presented in Table 1 . The differences between iron supplements and placebo only for total bacteria count TBC at 30 o C were observed.
The results obtained on Soyabean Casein Digest Agar (SCDA) presented higher differentiation. The used medium supports the growth of wide variety of organisms even that of fastidious ones such as Neisseria spp., Listeria spp. and Brucella spp., etc. Tryptone Soya Agar is recommended by various pharmacopoeias as sterility testing medium and antimicrobial preservative-effective test.
Analysis of bacteria colony number growth on SCDA medium incubated at 25 o C or 37 o C showed some patterns:
in fi rst two months of storage the microbial stability of tested bacteria were very high. No bacteria growth were observed independently from initial storage temperature (4 o C or 25 o C or 37 o C), -after one year of storage the highest total bacteria and mold number (CFU/g) in all tested iron supplements and placebo was obtained for samples stored at 37 o C, respectively the lowest was reported for samples stored at 4 o C, -in placebo samples, independently from initial storage temperature (4 o C or 25 o C or 37 o C) the higher total bacteria and mold number (CFU/g) were observed (6.0 ×10 2 CFU/g), -total bacteria and mold number (CFU/g) in iron supplements was lower than acceptable number, declared in microbial certifi cate provided by both lyophilized pig blood producers, total bacteria and mold number (CFU/g) in placebo was lower than quality requirements that are expected for dry vegetables. Figure 2 presents the temperature dependences of DC magnetic susceptibility (χ = M/H, where M is magnetisation and H an external magnetic fi eld) in ZFC and FC modes for AproFER 1000 and AproTHEM. Figure 3 shows the dependence of magnetization on an external magnetic fi eld measured at 2 K. DC magnetization measurements have shown that the concentration of magnetic centers in AproFER 1000 is about 6 times greater than in AproTHEM (Figures 2 and 3 ). Magnetization of AproTHEM at high temperatures and in high applied magnetic fi elds is negative because the diamagnetism of Table 1 . Selected microbial parameters of AproFER 1000, AproTHEM, and Placebo samples gnetic susceptibility in ZFC and FC modes showed no existence of the superparamagnetic state as in 21 . Figure 4 shows the EPR spectra of AproFER 1000 and AproTHEM registered at different temperatures. As they are very complicated we will focus on the approach described in the work of Moreira et al. 21 In addition other lines are also visible that occur due to the localized magnetic moments 20 . Some of them can be observed at high temperatures due to appropriate relaxation times (see inset in Fig. 4) . In both samples a few different EPR components were observed at room temperature (Fig.  5 ) attributed to free radicals and transferrin (centered at g eff = 4.28(2) 33, 34 . A broad resonance line centered at g eff = 2.1 is due to ferritin 20 . The difference between the number of magnetic centers registered in DC magnetization and EPR measurements might be explained by the fact that some complexes will be silent in one of these methods due to different relaxation times (long vs. short). Table 2 shows that hemoglobin and ferritin have signifi cantly increased concentration in Aprofer 1000, the capsule dominates over the paramagnetism of the sample. The 238 nm emission line characteristic of the iron has shown that in Placebo the iron concentration is 20 times smaller than in AproTHEM. The concentration of iron ions in AproFER 1000 is three times greater than in AproTHEM. DC magnetization measurements provided two times bigger concentration of magnetic centers which could be the consequence of different concentrations of divalent and trivalent iron complexes. It is not excluded that an additional magnetic response may arise from the free radicals or other complexes containing other magnetic ions such as divalent copper. The Curie-type behavior of temperature dependence of magnetic susceptibility, χ(T) = C/T, was observed at low temperatures in both samples. Due to the competition of different interactions resulting from the existence of many types of magnetic centers (as will be demonstrated in EPR studies) a disordered magnetic state could be formed at low temperature 32 . Figure 3 presents the magnetic fi eld dependence of magnetization taken at T = 2K which confi rms that AproFER 1000 has several times more magnetic centers. The dependence of magnetization on magnetic fi eld registered at T = 300 K showed that in AproTHEM the dominating contribution comes from the diamagnetic capsule. This also confi rms that AproFER 1000 has much higher concentration of magnetic centers. The temperature dependence of ma- Ferritin is associated with the oxidation of divalent to trivalent iron and plays an important role in the living matter 37, 38 .
EPR measurements of the basic component showed a radical change in the amount of paramagnetic species being the result of oxidation of iron ions followed by the transition to a lower level of oxidization and thus signifi cant change of the magnetic moment. It is not excluded that other components were taking part in this process. Additionally, an intense resonant signal at g eff = 3.47 was observed in Aprofer 1000 (Fig. 4) .
In hemoproteins, bis-histidine hemes having two axial histidine ligands displayed EPR spectra with g eff values between 2.9 and 3.6 22 . The g-factor values of these complexes depend on the relative orientation of two imidazole rings and on the orientation of these imidazoles with respect to the porphyrin plane. Those rings are in an orthogonal conformation Type I hemichrome or HALS with iron low-spin complexes 22, 38 . Figure 6 shows the temperature dependence of the intensities of hemoglobin, transferrin and free radicals for AproFER 1000 and AproTHEM, respectively. Temperature dependence of the resonance line intensity indicate that the free radicals and complexes of trivalent iron ions change the relaxation time at low temperatures and the phenomenon is connected with dominate the spin-spin processes. Figure 7 shows temperature dependence of the inverse intensities of the EPR spectra of hemoglobin, transferrin and free radicals in AproFER 1000 and AproTHEM, respectively. For hemoglobin and transferrin a ferromagnetic interaction is observed and opposite for free radicals antiferromagnetic which is more intense at higher temperatures. Studies of magnetic properties of blood often show the existence of the superparamagnetic state 34 . Most frequently the superparamagnetic state is observed in a system of non-interacting or weakly-interacting magnetic nanoparticles (or magnetic clusters). For high concentration of magnetic complexes an agglomeration phenomenon can occur that prevents formation of superparamagnetic phase.
The role of iron complex producing an EPR line at g eff = 3.47 in AproFER 1000 is at present unknown. Figure 8 presents the EPR spectra AproFER 100 0 at 2 K stored at different temperatures (4 o C, 25 o C and 37 o C).It can be seen that there is no essential differences on the concentration of magnetic centers and spectra of all three samples are practically the same. 
CONCLUSIONS
No signifi cant changes were observed at the EPR spectra of AproFER 1000 stored at different conditions for 12 months. Although the growth of bacteria was observed on the iron supplement samples, the tablets content is used as a carbon or energy sources for saprophytic bacteria. Nonetheless no changes in iron content or forms were observed. There were no pathogenic bacteria on the supplements so they may be taken safely by patients with iron defi ciency anemia.
The EPR studies showed a high concentration of iron in AproFER 1000 and AproTHEM products. It can be stated that this products is a rich source of bivalent iron and can be used as an iron supplement. Since AproTHEM shows very good solubility in water, opposite to Apro-FER 1000, it is more recommended for this application.
